GASTRIC MOTILITY DISORDER DRUG MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Gastric Motility Disorder Drug Market, By Disorder Type (Upper Digestive Tract and Lower Digestive Tract), By Drug Class (Antacids, Antidiarrheals, Calcium-channel Blockers, H2 Blockers, Proton Pump Inhibitors, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024
Code : CMI6849
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Gastric Motility Disorder Drug Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Ageing global population

Another important driver for the gastric motility drug market is the steadily ageing population worldwide. Advances in public healthcare have contributed to increased life expectancy which means the proportion of elderly individuals is growing in most countries and regions. This phenomenon has significant implications for the healthcare industry since the risk of developing gastric motility issues rises considerably with age. The elderly tend to experience higher rates of comorbidities like Parkinson's disease, diabetes, and arthritis - all of which can potentially impair normal stomach function over time. Age-related decline in lean muscle mass and immunity also renders older patients more prone to experiencing gastric emptying problems, nausea, vomiting, and discomfort after meals.

Key Players Insights